Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
DDOG
|
Olivier Pomel
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 19,226 Reduced 4.82% |
$2,959,265
$153.92 p/Share
|
Dec 18
2024 |
|
IDCC
|
Lawrence Liren Chen
President and CEO |
SELL
Open market or private sale
|
Direct | 5,891 Reduced 3.46% |
$1,150,806
$195.35 p/Share
|
Dec 18
2024 |
|
VCIF
|
Joan Y Mccabe
Director |
BUY
Open market or private purchase
|
Direct | 18,079 Added 37.32% |
$144,993
$8.02 p/Share
|
Dec 18
2024 |
|
PCTY
|
Steven I Sarowitz
Director |
SELL
Open market or private sale
|
Direct | 4,715 Reduced 0.06% |
$957,239
$203.02 p/Share
|
Dec 18
2024 |
|
DORM
|
Steven L Berman
Director |
SELL
Open market or private sale
|
Direct | 130 Reduced 0.02% |
$17,550
$135.0 p/Share
|
Dec 18
2024 |
|
PFXNZ
|
David A Lorber
CHAIRMAN AND CEO |
BUY
Open market or private purchase
|
Direct | 12,871 Added 8.48% |
$616,134
$47.87 p/Share
|
Dec 18
2024 |
|
KFS
|
Joseph Stilwell
Director |
SELL
Open market or private sale
|
Indirect | 365,000 Reduced 0.0% |
$3,076,950
$8.43 p/Share
|
Dec 18
2024 |
|
TYG
|
Prudential Financial Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,500,000 Added 0.0% |
$15,000,000
$10.0 p/Share
|
Dec 18
2024 |
|
TYG
|
Prudential Financial Inc
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 25,000,000 Added 0.0% |
$18,250,000,000,000
$730000.0 p/Share
|
Dec 18
2024 |
|
HGBL
|
David Van Ludwig
President of subsidiary |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.0% |
$17,500
$1.75 p/Share
|
Dec 18
2024 |
|
CLMT
|
Jennifer Straumins |
SELL
Open market or private sale
|
Direct | 37,861 Reduced 3.1% |
$810,982
$21.42 p/Share
|
Dec 18
2024 |
|
MDBH
|
Anthony Digiandomenico
Co-Founder |
SELL
Open market or private purchase
|
Direct | 1,000 Reduced 1.24% |
$6,200
$6.2 p/Share
|
Dec 18
2024 |
|
AESI
|
Stacy Hock |
SELL
Open market or private sale
|
Direct | 8,571 Reduced 0.93% |
$193,276
$22.55 p/Share
|
Dec 18
2024 |
|
AXR
|
Robotti Robert
Director |
SELL
Open market or private sale
|
Indirect | 201 Reduced 0.0% |
$6,381
$31.75 p/Share
|
Dec 18
2024 |
|
LOCL
|
Kathleen Valiasek
President and CFO |
BUY
Open market or private purchase
|
Direct | 600 Added 0.13% |
$1,205
$2.01 p/Share
|
Dec 18
2024 |
|
PRLD
|
Krishna Vaddi
CEO |
BUY
Open market or private purchase
|
Direct | 100,000 Added 7.89% |
$93,000
$0.93 p/Share
|
Dec 18
2024 |
|
USEG
|
Ryan Lewis Smith
CEO |
BUY
Open market or private purchase
|
Direct | 500 Added 0.06% |
$740
$1.48 p/Share
|
Dec 18
2024 |
|
VRSN
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 84,000 Added 0.0% |
$16,264,080
$193.62 p/Share
|
Dec 18
2024 |
|
OXY
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 2,805,513 Added 0.0% |
$130,568,575
$46.54 p/Share
|
Dec 18
2024 |
|
SIRI
|
Berkshire Hathaway Inc |
BUY
Open market or private purchase
|
Indirect | 1,454,467 Added 0.0% |
$32,318,256
$22.22 p/Share
|
Dec 18
2024 |
|
GRX
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 20,408 Added 0.0% |
$198,773
$9.74 p/Share
|
Dec 18
2024 |
|
NRGX
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 10,392 Added 0.0% |
$258,968
$24.92 p/Share
|
Dec 18
2024 |
|
NMAI
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 6,031 Reduced 0.0% |
$73,698
$12.22 p/Share
|
Dec 18
2024 |
|
NKTR
|
Howard W Robin
President & CEO |
SELL
Open market or private sale
|
Direct | 85,035 Reduced 7.11% |
$84,184
$0.99 p/Share
|
Dec 18
2024 |
|
SFM
|
Jack Sinclair
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 5,714 Reduced 3.61% |
$782,075
$136.87 p/Share
|
Dec 18
2024 |
|
EQH
|
Nick Lane |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 15.0% |
$1,142,250
$45.69 p/Share
|
Dec 18
2024 |
|
RBRK
|
Kiran Kumar Choudary
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,800 Reduced 0.52% |
$130,860
$72.7 p/Share
|
Dec 18
2024 |
|
ENX
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,800 Added 0.0% |
$46,464
$9.68 p/Share
|
Dec 18
2024 |
|
EVM
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 18,104 Added 0.0% |
$169,091
$9.34 p/Share
|
Dec 18
2024 |
|
MIO
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 17,915 Added 0.0% |
$215,517
$12.03 p/Share
|
Dec 18
2024 |
|
LBRDA
|
Gregory B Maffei
President/CEO |
SELL
Open market or private sale
|
Direct | 125,000 Reduced 8.01% |
$9,967,500
$79.74 p/Share
|
Dec 18
2024 |
|
MAV
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 34,240 Added 0.0% |
$294,464
$8.6 p/Share
|
Dec 18
2024 |
|
EVCM
|
Eric Richard Remer
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 8,469 Reduced 0.0% |
$98,579
$11.64 p/Share
|
Dec 18
2024 |
|
MHI
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 11,715 Added 0.0% |
$110,355
$9.42 p/Share
|
Dec 18
2024 |
|
XENE
|
Sherry Aulin
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 18,709 Reduced 100.0% |
$770,997
$41.21 p/Share
|
Dec 18
2024 |
|
EWCZ
|
Nital P. Scott |
SELL
Open market or private sale
|
Direct | 15,048 Reduced 51.43% |
$87,278
$5.8 p/Share
|
Dec 18
2024 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,060,757
$259.28 p/Share
|
Dec 18
2024 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,060,757
$259.28 p/Share
|
Dec 18
2024 |
|
ZS
|
Remo Canessa
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,212 Reduced 1.46% |
$641,340
$199.67 p/Share
|
Dec 18
2024 |
|
EVER
|
David Brainard
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 21,079 Reduced 15.35% |
$380,054
$18.03 p/Share
|
Dec 18
2024 |
|
DSGN
|
Deepa Prasad |
SELL
Open market or private sale
|
Direct | 3,806 Reduced 15.99% |
$23,863
$6.27 p/Share
|
Dec 18
2024 |
|
ZS
|
Robert Schlossman
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 3,035 Reduced 2.67% |
$583,509
$192.26 p/Share
|
Dec 18
2024 |
|
GH
|
Musa Tariq
Director |
SELL
Open market or private sale
|
Direct | 116 Reduced 3.96% |
$4,042
$34.85 p/Share
|
Dec 18
2024 |
|
RNA
|
Teresa Mc Carthy
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 11,151 Reduced 11.86% |
$364,191
$32.66 p/Share
|
Dec 18
2024 |
|
RNA
|
Sarah Boyce
President and CEO |
SELL
Open market or private sale
|
Direct | 31,855 Reduced 10.72% |
$1,040,384
$32.66 p/Share
|
Dec 18
2024 |
|
RNA
|
Michael F Mac Lean
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 11,151 Reduced 11.85% |
$364,191
$32.66 p/Share
|
Dec 18
2024 |
|
RNA
|
W. Michael Flanagan
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 12,742 Reduced 14.92% |
$416,153
$32.66 p/Share
|
Dec 18
2024 |
|
CLXT
|
Gerhard Prante
Director |
SELL
Open market or private sale
|
Direct | 1,150 Reduced 2.14% |
$4,312
$3.75 p/Share
|
Dec 18
2024 |
|
PHR
|
David Linetsky
SVP, Life Sciences |
SELL
Open market or private sale
|
Indirect | 24 Reduced 0.0% |
$609
$25.38 p/Share
|
Dec 18
2024 |
|
PHR
|
Allison C Hoffman
General Counsel & Secretary |
SELL
Open market or private sale
|
Direct | 3,495 Reduced 2.92% |
$86,955
$24.88 p/Share
|
Dec 18
2024 |